As of January 22, 2025, TME Pharma NV (ALTME.PA) has a market cap of $7.300 million USD. According to our data, TME Pharma NV is ranked No.8958 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $7.30 M |
-0.67%
|
Dec 31, 2024 | $7.35 M |
-67.39%
|
Dec 29, 2023 | $22.54 M |
1,986.97%
|
Dec 30, 2022 | $1.08 M |
-94.80%
|
Dec 31, 2021 | $20.78 M |
-58.36%
|
Dec 31, 2020 | $49.92 M |
-3.44%
|
Dec 31, 2019 | $51.69 M |
-42.94%
|
Dec 31, 2018 | $90.59 M |
-83.94%
|
Dec 29, 2017 | $0.56 B |
-71.12%
|
Dec 30, 2016 | $1.95 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sea (Garena)
SE
|
$67.98 B |
5.389 B
|
Singapore
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Market Cap | = | ALTME.PA Stock Price | * | ALTME.PA Shares Outstanding |
= | $0.08 | * | 94.12 M | |
= | $7.30 M |